Solventum Corporation (SOLV) is a publicly traded Healthcare sector company. As of September 2, 2026, SOLV trades at $92.84 with a market cap of $15.48B and a P/E ratio of 10.36. SOLV moved +1.04% today. Year to date, SOLV is +16.30%; over the trailing twelve months it is +28.71%. Its 52-week range spans $60.70 to $94.16. Analyst consensus is buy with an average price target of $98.50. Rallies surfaces SOLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SOLV, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $92.84 |
| Market Cap | $15.48B |
| P/E Ratio | 10.36 |
| EPS | $8.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $94.16 |
| 52-Week Low | $60.70 |
| Volume | 513.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $8.32B |
| Net Income | $1.56B |
| Gross Margin | 53.47% |
10 analysts cover SOLV: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $98.50.